These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9684790)

  • 1. Influence of low molecular weight heparin and low molecular weight dextran sulfate on the inhibition of coagulation factor XIa by serpins.
    Mauron T; Lämmle B; Wuillemin WA
    Thromb Haemost; 1998 Jul; 80(1):82-6. PubMed ID: 9684790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa.
    Wuillemin WA; Eldering E; Citarella F; de Ruig CP; ten Cate H; Hack CE
    J Biol Chem; 1996 May; 271(22):12913-8. PubMed ID: 8662679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
    Rezaie AR; Sun MF; Gailani D
    Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of factor Xia in vivo: studies in chimpanzees and in humans.
    Wuillemin WA; Hack CE; Bleeker WK; Biemond BJ; Levi M; ten Cate H
    Thromb Haemost; 1996 Oct; 76(4):549-55. PubMed ID: 8902995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
    Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
    J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.
    Yang L; Sun MF; Gailani D; Rezaie AR
    Biochemistry; 2009 Feb; 48(7):1517-24. PubMed ID: 19178150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of factor XIa in human plasma assessed by measuring factor XIa-protease inhibitor complexes: major role for C1-inhibitor.
    Wuillemin WA; Minnema M; Meijers JC; Roem D; Eerenberg AJ; Nuijens JH; ten Cate H; Hack CE
    Blood; 1995 Mar; 85(6):1517-26. PubMed ID: 7534133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
    Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
    Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress curve analysis of the kinetics with which blood coagulation factor XIa is inhibited by protease nexin-2.
    Scandura JM; Zhang Y; Van Nostrand WE; Walsh PN
    Biochemistry; 1997 Jan; 36(2):412-20. PubMed ID: 9003194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].
    Drozd NN; Tolstenkov AS; Bannikova GE; Miftakhova NT; Lapikova ES; Makarov VA; Varlamov VP
    Eksp Klin Farmakol; 2007; 70(6):19-24. PubMed ID: 18318190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human pancreatic proteinases by human plasma alpha2-antiplasmin and antithrombin.
    Nobar SM; Guy-Crotte O; Rabaud M; Bieth JG
    Biol Chem; 2004 May; 385(5):423-7. PubMed ID: 15196003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of human factor XIa-inhibitor complexes in rats.
    Wuillemin WA; Bleeker WK; Agterberg J; Rigter G; ten Cate H; Hack CE
    Br J Haematol; 1996 Jun; 93(4):950-4. PubMed ID: 8703832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
    Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
    Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
    Fiore MM; Mackie IM
    Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the contact system in patients with a first acute myocardial infarction.
    Konings J; Govers-Riemslag JW; Spronk HM; Waltenberger JL; ten Cate H
    Thromb Res; 2013 Jul; 132(1):138-42. PubMed ID: 23746628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor.
    Knauer DJ; Majumdar D; Fong PC; Knauer MF
    J Biol Chem; 2000 Dec; 275(48):37340-6. PubMed ID: 10973954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants.
    Lin J; Deng H; Jin L; Pandey P; Quinn J; Cantin S; Rynkiewicz MJ; Gorga JC; Bibbins F; Celatka CA; Nagafuji P; Bannister TD; Meyers HV; Babine RE; Hayward NJ; Weaver D; Benjamin H; Stassen F; Abdel-Meguid SS; Strickler JE
    J Med Chem; 2006 Dec; 49(26):7781-91. PubMed ID: 17181160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.